Circulating IL-13 Is Associated with De Novo Development of HCC in HCV-Infected Patients Responding to Direct-Acting Antivirals

Circulating IL-13 Is Associated with De Novo Development of HCC in HCV-Infected Patients Responding to Direct-Acting Antivirals

Direct-acting antivirals (DAAs) are highly effective in targeting hepatitis C virus (HCV) infections, but the incidence of HCV-related hepatocellular carcinoma (HCC) remains still high. In this study, we investigated a cohort of HCV-infected patients treated with DAAs who were followed up for 4 year...

Full description

Bibliographic Details
Main Authors: Zuzana Macek Jílková, Arnaud Seigneurin, Celine Coppard, Laurissa Ouaguia, Caroline Aspord, Patrice N. Marche, Vincent Leroy, Thomas Decaens
Format: Article
Language:English
Published: MDPI AG 2020-12-01
Series:Cancers
Subjects:
hepatitis C virus
hepatocellular carcinoma
direct-acting antivirals
IL-13
IL-4
immune profile
Online Access:https://www.mdpi.com/2072-6694/12/12/3820

Internet

https://www.mdpi.com/2072-6694/12/12/3820

Similar Items